Header Logo

Connection

JEFFREY E GERSHENWALD to Dacarbazine

Back to Details
This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about Dacarbazine.
JEFFREY E GERSHENWALD
Connection Strength
0.018
Dacarbazine
  1. A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence. Melanoma Res. 2009 Feb; 19(1):42-9.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.